Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.54
+0.62 (3.46%)
At close: Mar 4, 2026, 4:00 PM EST
18.54
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:10 PM EST
Bicara Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Bicara Therapeutics stock have an average target of 25.88, with a low estimate of 11 and a high estimate of 40. The average target predicts an increase of 39.59% from the current stock price of 18.54.
Analyst Consensus: Buy
* Price targets were last updated on Jan 29, 2026.
Analyst Ratings
The average analyst rating for Bicara Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 1 | 1 | 2 | 2 |
| Buy | 4 | 4 | 3 | 3 | 4 | 4 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 5 | 6 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Initiates $31 | Buy | Initiates | $31 | +67.21% | Jan 29, 2026 |
| Wedbush | Wedbush | Buy Reiterates $30 | Buy | Reiterates | $30 | +61.81% | Jan 13, 2026 |
| BTIG | BTIG | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +51.02% | Jan 8, 2026 |
| Mizuho | Mizuho | Hold Initiates $18 | Hold | Initiates | $18 | -2.91% | Dec 18, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | -40.67% | Nov 11, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.55
from -4.05
EPS Next Year
-3.09
from -2.55
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.46 | -2.43 | ||||
| Avg | -2.55 | -3.09 | ||||
| Low | -2.55 | -3.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.